Sweet pills: How pharma stocks delivered bumper returns to Indian investors, defying 2026 whiplashIndian pharma stocks are outperforming the market, offering strong returns to investors. This resilience is driven by robust domestic deman...
US says BYD, Baidu and Alibaba are aiding China's militaryAmerica has released a new list of Chinese companies it believes support Beijing's military. Major firms like Alibaba, Baidu, and BYD are i...
US says BYD, Baidu and Alibaba and other tech giants are aiding China's militaryThe U.S. has updated its list of Chinese companies aiding Beijing's military, adding tech giants like Alibaba and Baidu, alongside chipmake...
Alibaba, BYD, Baidu are helping China military - Pentagon makes shocking claimsUS-China relations: Pentagon's update on Monday comes months after it briefly released -- then withdrew -- an earlier version of the list w...
Chinese airline passenger spots Boeing 737 anomaly in viral video claims, airline grounds plane after inspectionA Shenzhen Airlines flight was canceled after a passenger alerted cabin crew to a suspected irregularity on the aircraft's wing before boar...
India's 'young tigresses' to face China in U17 Asian Cup quarter-finalsIndia's U17 women's team will face hosts China in the high-stakes quarter-finals of the AFC U17 Women's Asian Cup China 2026 at the Suzhou ...
Pentagon seeks to add Alibaba, Baidu, BYD to China military listChinese military: It is not immediately clear if the companies have been added to the Pentagon's 1260H list of Chinese companies deemed mil...
Doing nothing could be the riskiest thing of allThe cost of “doing nothing” in markets can indeed be substantial, but that pales in comparison to the cost of complacency when the margin o...
China's pharma firm WuXi AppTec shared US client's data with BeijingThe US government is concerned that certain Chinese biotech companies are contributing technology or research and development for use by Ch...
China shares end higher as inflation data raises easing hopesThe blue-chip CSI300 index was up 0.39%, with its financial sector sub-index higher by 0.82%, the real-estate index up 1.66% and the health...
China's Brii says its COVID-19 antibody cocktail retains activity against OmicronTest details for the dual-antibody treatment, which last week became the first approved COVID-19 antibody cocktail in China, would not be a...
Hong Kong shares end lower, dragged by property, financials and techChina Evergrande Group plunged nearly 12% to its lowest in more than six years, after it warned of a risk of cross-default as real estate s...
Pfizer to halt biosimilar output in China, sell assets to WuXi BiologicsThe pharmaceutical industry increasingly relies for its profits on costly biologic drugs, made from living organisms that are tougher and m...
Alibaba, Xiaomi to join Hong Kong's Hang Seng IndexThe change announced by the Hang Seng Indexes Company on Friday was made possible after the 50-year-old benchmark's publisher changed the r...
Syngene plans to scale up for biologicsSyngene, an arm of Biocon, is expanding its capital investment as it waits to complete a 40-acre, $100-million research facility in Mangalo...
Syngene International makes stellar debut, ends day up 24% over issue priceIt hit an intraday high of Rs 318.20 over its issue price, before settling the day at Rs 310.40, up 24.16 per cent on the BSE.
Syngene's valuations are fair, investors need to invest in its growth story: Kiran Mazumdar-ShawIn an interview with ET Now, Kiran Mazumdar-Shaw, CMD, Biocon, talks about the Syngene IPO and the growth prospects involved.